Targeting the hypoxia signaling pathway with nanomedicine to reverse immunotherapy resistance
{{output}}
Immunotherapy has emerged as a major therapeutic strategy for cancer; however, immunotherapy resistance remains a significant challenge. Hypoxia, a key hallmark of the tumor microenvironment resulting from the imbalance between the high oxygen demand of rapidl... ...
